We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





On-Skin, Wearable Bioelectronic Device Could Aid Early Detection of COVID-19

By HospiMedica International staff writers
Posted on 25 Feb 2021
A wearable, bioelectronic device could wirelessly transmit a person’s vital signs - potentially providing critical information for early detection of health issues such as COVID-19 or heart disease - to a healthcare provider, eliminating the need for an in-person visit while also saving lives.

University of Missouri (Columbia, MO, USA) engineers are advancing the commercial market for wearable bioelectronics by developing a large-scale manufacturing plan for a customizable device capable of simultaneously tracking multiple vital signs such as blood pressure, heart activity and skin hydration. More...
The project has received a USD 500,000 grant from the National Science Foundation to plan for large-scale manufacturing of an on-skin, wearable bioelectronic device. The grant builds on some of the engineers’ previous work demonstrating a proof of concept of a small patch that works as a breathable and waterproof on-skin electronic device with passive cooling capabilities. Now, the team is working to increase production of that concept device for large-scale distribution.

Existing wearable devices usually consist of bioelectronics supported by a flexible, solid material - typically plastic or silicone - called a substrate. The engineers aim to optimize the material to be soft, breathable, comfortable, lightweight and waterproof. Also, in order to mass produce the bioelectronic sensors, the team is researching how to print them directly onto the supportive material using a method called mask-free inkjet printing.

“While the biosensors for these devices have already been developed, we now want to combine them to mass produce a porous patch with multiple bioelectronic components,” said Zheng Yan, an assistant professor in the College of Engineering. “The components can also be customized to fit the individual health needs of the user.”

“In the future, if we want to be able to widely implement the use of wearable biomedical devices, due to the size of production it should have a low manufacturing cost,” added Yan. “Therefore, using this grant we want to determine how to achieve continuous, scalable fabrication of such devices in an effort to keep our production costs as low as possible and transfer those cost savings to the consumer.”


Related Links:
University of Missouri


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.